Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1983 1
1989 2
1990 2
1992 1
1993 1
1994 1
1995 1
1996 3
1998 1
1999 2
2000 2
2001 7
2002 1
2003 2
2004 2
2005 6
2006 2
2007 6
2008 3
2009 2
2010 8
2011 8
2012 6
2013 9
2014 9
2015 6
2016 1
2017 3
2018 3
2019 4
2020 7
2021 8
2022 5
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines for the Pharmacotherapy of Schizophrenia in Adults.
Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M. Remington G, et al. Can J Psychiatry. 2017 Sep;62(9):604-616. doi: 10.1177/0706743717720448. Epub 2017 Jul 13. Can J Psychiatry. 2017. PMID: 28703015 Free PMC article. Review.
RESULTS: Recommendations can be categorized into 6 areas that include 1) first-episode schizophrenia, 2) acute exacerbation, 3) relapse prevention and maintenance treatment, 4) treatment-resistant schizophrenia, 5) clozapine-resistant schizophrenia, and 6) specific …
RESULTS: Recommendations can be categorized into 6 areas that include 1) first-episode schizophrenia, 2) acute exacerbation, 3 …
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. Joshi YB, et al. Am J Psychiatry. 2021 Sep 1;178(9):838-847. doi: 10.1176/appi.ajp.2020.20081212. Epub 2021 May 14. Am J Psychiatry. 2021. PMID: 33985348 Free PMC article.
Patients with a diagnosis of schizophrenia or schizoaffective disorder (N=1,120) were recruited from the community at five U.S. universities as part of the Consortium on the Genetics of Schizophrenia-2. For each participant, prescribed medications were rated and sum …
Patients with a diagnosis of schizophrenia or schizoaffective disorder (N=1,120) were recruited from the community at five U.S. universities …
Cannabis and schizophrenia.
McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. McLoughlin BC, et al. Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3. Cochrane Database Syst Rev. 2014. PMID: 25314586 Free PMC article. Review.
SELECTION CRITERIA: We included all randomised controlled trials involving cannabinoids and schizophrenia/schizophrenia-like illnesses, which assessed:1) treatments to reduce cannabis use in people with schizophrenia;2) the effects of cannabinoids on people with sch …
SELECTION CRITERIA: We included all randomised controlled trials involving cannabinoids and schizophrenia/schizophrenia-like illnesses, whic …
Electroretinographic anomalies in schizophrenia.
Demmin DL, Davis Q, Roché M, Silverstein SM. Demmin DL, et al. J Abnorm Psychol. 2018 May;127(4):417-428. doi: 10.1037/abn0000347. J Abnorm Psychol. 2018. PMID: 29745706
These findings (1) replicate and extend prior studies demonstrating reduced photoreceptor (both rod and cone) and bipolar cell functioning in schizophrenia; (2) indicate that retinal ganglion function abnormality can also be detected using fERG; and (3) indicate tha …
These findings (1) replicate and extend prior studies demonstrating reduced photoreceptor (both rod and cone) and bipolar cell functioning i …
Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies.
Miller BJ, Culpepper N, Rapaport MH, Buckley P. Miller BJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:92-100. doi: 10.1016/j.pnpbp.2012.03.010. Epub 2012 Apr 1. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 22510462 Review.
In this paper, we review human studies of 1) prenatal inflammation and risk of schizophrenia, 2) inflammation as a potential common mediator of several prenatal risk factors for schizophrenia other than prenatal infections, 3) prenatal inflammation and immune functi …
In this paper, we review human studies of 1) prenatal inflammation and risk of schizophrenia, 2) inflammation as a potential c …
Lithium for schizophrenia.
Leucht S, Kissling W, McGrath J. Leucht S, et al. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003834. doi: 10.1002/14651858.CD003834.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636738 Updated. Review.
These should concentrate on two target groups: 1) people with no affective symptoms, so that trialists can determine whether lithium has an effect on the core symptoms of schizophrenia, 2) people with schizoaffective disorders for whom lithium is widely used in clin …
These should concentrate on two target groups: 1) people with no affective symptoms, so that trialists can determine whether lithium has an …
Lithium for schizophrenia.
Leucht S, McGrath J, Kissling W. Leucht S, et al. Cochrane Database Syst Rev. 2003;(3):CD003834. doi: 10.1002/14651858.CD003834. Cochrane Database Syst Rev. 2003. PMID: 12917990 Updated. Review.
These should concentrate on two target groups: 1) people with no affective symptoms, so that trialists can determine whether lithium has an effect on the core symptoms of schizophrenia, 2) people with schizoaffective disorders for whom lithium is widely used in clin …
These should concentrate on two target groups: 1) people with no affective symptoms, so that trialists can determine whether lithium has an …
The dietary pattern of patients with schizophrenia: a systematic review.
Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. Dipasquale S, et al. J Psychiatr Res. 2013 Feb;47(2):197-207. doi: 10.1016/j.jpsychires.2012.10.005. Epub 2012 Nov 12. J Psychiatr Res. 2013. PMID: 23153955 Free article. Review.
As a poor diet can predispose to the development of metabolic abnormalities, the aims of this review are to clarify: 1) the dietary patterns of patients with schizophrenia, 2) the association of these dietary patterns with a worse metabolic profile, and 3) the possi …
As a poor diet can predispose to the development of metabolic abnormalities, the aims of this review are to clarify: 1) the dietary patterns …
Core of schizophrenia: estrangement, dementia or neurocognitive disorder?
Urfer-Parnas A, Mortensen EL, Parnas J. Urfer-Parnas A, et al. Psychopathology. 2010;43(5):300-11. doi: 10.1159/000318814. Epub 2010 Jul 15. Psychopathology. 2010. PMID: 20639690 Review.
METHODS: This study addresses the following questions: (1) Did the classic authors equate degenerative dementia with schizophrenia? (2) Is there empirical evidence pointing to a close similarity between schizophrenia and organic dementia? ...
METHODS: This study addresses the following questions: (1) Did the classic authors equate degenerative dementia with schizophrenia? ( …
The DISC locus in psychiatric illness.
Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK. Chubb JE, et al. Mol Psychiatry. 2008 Jan;13(1):36-64. doi: 10.1038/sj.mp.4002106. Epub 2007 Oct 2. Mol Psychiatry. 2008. PMID: 17912248 Review.
Two novel genes were identified at this locus and due to the high prevalence of schizophrenia in this family, they were named Disrupted-in-Schizophrenia-1 (DISC1) and Disrupted-in-Schizophrenia-2 (DISC2). DISC1 encodes a novel multifunctional scaffold protein, where …
Two novel genes were identified at this locus and due to the high prevalence of schizophrenia in this family, they were named Disrupted-in-S …
115 results